This article is more than 5 years old. Information may no longer be current.

STAAR Surgical reports $13.6 million in third quarter product sales

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

MONROVIA, Calif. — STAAR Surgical recorded $13.6 million in total product sales for the third quarter, an increase of 2.4% over the same period of last year. The year-over-year increase in sales during the quarter was led by increased international sales, which grew 17% compared with the third quarter 2006, according to a press release from the company.

Global third quarter cataract sales declined 1.5% compared with the third quarter 2006, while total refractive sales increased 17.1%.

For the first 9 months of 2007, product sales totaled $43.5 million, an increase of 4.7% over the same period 2006. The increase in 9-month sales was also led by international product sales, which grew 16.6% to $28.5 million.

International third quarter sales increased 16.9% over the third quarter 2006 to total $8.9 million. Also compared with the third quarter 2006, third quarter 2007 international refractive sales increased 44.9% to $2.29 million and cataract sales increased 9.6% to $6.5 million.

U.S. sales for the third quarter decreased 16.9% compared with the same period last year and totaled $4.74 million. Also compared with the third quarter 2006, third quarter 2007 U.S. refractive sales decreased 16.2% to $1.1 million and U.S. cataract sales decreased 16.8% to $3.6 million, according to the release.

For the first 9 months of 2007, U.S. sales totaled $14.99 million, a 12.2% decrease compared with the same period 2006, and U.S. refractive sales decreased 4.6% to $3.3 million.

For the third quarter 2007, STAAR reported a net loss of $3.8 million, or $0.13 per share, compared with a net loss of $2.8 million, or $0.11 per share, for the same period of 2006, according to the release.